0001209191-23-032996.txt : 20230530
0001209191-23-032996.hdr.sgml : 20230530
20230530182420
ACCESSION NUMBER: 0001209191-23-032996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230530
FILED AS OF DATE: 20230530
DATE AS OF CHANGE: 20230530
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacot Stanley Jr
CENTRAL INDEX KEY: 0001909085
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37383
FILM NUMBER: 23978284
MAIL ADDRESS:
STREET 1: 202 COUSTEAU PLACE STE 105
CITY: DAVIS
STATE: CA
ZIP: 95618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcadia Biosciences, Inc.
CENTRAL INDEX KEY: 0001469443
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100]
IRS NUMBER: 810571538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 COUSTEAU PLACE
STREET 2: SUITE 105
CITY: DAVIS
STATE: X1
ZIP: 95618
BUSINESS PHONE: 530-756-7077
MAIL ADDRESS:
STREET 1: 202 COUSTEAU PLACE
STREET 2: SUITE 105
CITY: DAVIS
STATE: CA
ZIP: 95618
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-30
0
0001469443
Arcadia Biosciences, Inc.
RKDA
0001909085
Jacot Stanley Jr
C/O ARCADIA BIOSCIENCES, INC.
5950 SHERRY LANE, SUITE 215
DALLAS
TX
75225
0
1
0
0
Chief Executive Officer
0
Common stock
2023-05-30
4
P
0
5000
4.31
A
5000
D
This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Stanley E. Jacot, Jr., by Attorney-in-fact, Thomas J. Schaefer
2023-05-30